Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis
暂无分享,去创建一个
A. Randolph | G. Alter | A. Fasano | A. Dionne | A. Edlow | L. Yonker | M. Arditi | T. Novak | B. Julg | David R. Walt | Y. Bartsch | A. Kane | Janet Chou | Manuella Lahoud-Rahme | D. Balaguru | Chi-An Cheng | Y. Senussi | B. Boribong | M. D. Burns | Jameson P. Davis | M. Loiselle | Z. Swank | Eleanor Burgess | J. Chou | Zoe N Swank
[1] T. Härkänen,et al. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents , 2022, JAMA cardiology.
[2] B. Tai,et al. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis , 2022, The Lancet Respiratory Medicine.
[3] M. Askenazi,et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19 , 2022, Nature Medicine.
[4] Manish M Patel,et al. Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents , 2022, The New England journal of medicine.
[5] A. Randolph,et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 , 2022, MMWR. Morbidity and mortality weekly report.
[6] D. Irimia,et al. Neutrophil Profiles of Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children , 2021, bioRxiv.
[7] E. Javouhey,et al. Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France. , 2021, JAMA.
[8] S. Heymans,et al. Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms , 2021, Nature Reviews Cardiology.
[9] B. McCrindle,et al. Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination , 2021, Circulation.
[10] R. Balicer,et al. Myocarditis after Covid-19 Vaccination in a Large Health Care Organization , 2021, The New England journal of medicine.
[11] E. Karlson,et al. A SARS‐CoV‐2 Neutralization Assay Using Single Molecule Arrays , 2021, Angewandte Chemie.
[12] G. Alter,et al. The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. , 2021, The Journal of clinical investigation.
[13] J. Newburger,et al. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children. , 2021, JAMA cardiology.
[14] P. Hotez,et al. Myocarditis With COVID-19 mRNA Vaccines , 2021, Circulation.
[15] J. Gargano,et al. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021 , 2021, MMWR. Morbidity and mortality weekly report.
[16] K. Batra,et al. In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA Vaccine , 2021, Circulation.
[17] D. Walt,et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. , 2021, The Journal of clinical investigation.
[18] A. Malhotra,et al. SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2 , 2021, Circulation research.
[19] M. H. Cheng,et al. HLA class I-associated expansion of TRBV11-2 T cells in Multisystem Inflammatory Syndrome in Children. , 2021, The Journal of clinical investigation.
[20] D. Lauffenburger,et al. Humoral signatures of protective and pathological SARS-CoV-2 infection in children , 2021, Nature Medicine.
[21] M. Desjardins,et al. Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients , 2021, Clinical Infectious Diseases.
[22] J. Mascola,et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.
[23] M. Caputo,et al. The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease , 2020, bioRxiv.
[24] L. Henderson,et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2 , 2020, Arthritis & rheumatology.
[25] M. H. Cheng,et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation , 2020, Proceedings of the National Academy of Sciences.
[26] D. Walt,et al. Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19 , 2020, Nature Biomedical Engineering.
[27] T. Gibson,et al. Ultra-sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease , 2020, Clinical chemistry.
[28] M. Malim,et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection , 2020, Nature Medicine.
[29] Yumei Leng,et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens , 2019, Science.
[30] U. Eriksson,et al. The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy. , 2016, Journal of the American College of Cardiology.
[31] Jeffrey M. Gerold,et al. Ad26/MVA Therapeutic Vaccination with TLR7 Stimulation in SIV-Infected Rhesus Monkeys , 2016, Nature.
[32] L. Cooper,et al. Cardiac myosin-Th17 responses promote heart failure in human myocarditis. , 2016, JCI insight.
[33] David M. Rissin,et al. A fully-automated, six-plex single molecule immunoassay for measuring cytokines in blood. , 2015, Journal of immunological methods.
[34] T. Maurer,et al. Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] W. Hong,et al. Amino Acids 1055 to 1192 in the S2 Region of Severe Acute Respiratory Syndrome Coronavirus S Protein Induce Neutralizing Antibodies: Implications for the Development of Vaccines and Antiviral Agents , 2005, Journal of Virology.